« Back to Covid-19 Home Page

COVID-19 clinical support

The current category is Managing Co-morbidities during Covid-19 pandemic

Medications

Palliative care medicines: see Palliative care section

DOAC Education Webinar

During the COVID pandemic, patients prescribed anticoagulants requiring frequent
monitoring (e.g. warfarin and INR) were advised to switch to DOACs where clinically
appropriate.

Whilst DOACs require blood tests to assess renal function throughout treatment, the
monitoring is predictable, less rigorous than INR testing with warfarin and is routinely
carried out in primary care.

In response to requests from SEL primary care committees, the SEL CVD medicines
working group has supported the changes to DOAC transfer of care with webinars
covering:
the changes to the transfer of care for patients prescribed DOACs (in place from 1st
October 2020)

• support/guidance to monitor patients taking DOACs to ensure safety and
effectiveness
• knowing when to seek advice and guidance from hospital teams or medicines
optimisation teams
• the prescribing of DOACs in elderly and frail patients and according to their risk/
benefit


Recordings from both webinars, along with the slides and Q&A documents from the
webinars can be found below

DOAC Education webinar – 12 November 2020

DOAC Education webinar – 17 November 2020

DOAC Education webinar slides – November 2020

Q&A from both DOAC Education webinars – November 2020

Structured Medication Review

Structured Medication Review for Diabetes Webinar – 19 August 2020

Mental health structured medication review webinar – 13 August 2020

Structured Medication Review for heart failure and hypertension webinar – 11 August 2020

ACEi/ARBs

Antibiotics

Anticoagulation

  • National guidance. Includes advice on management of patients taking warfarin in primary care during the Covid-19 pandemic, with recommendations to help minimise attendances

Chloroquine and hydroxychloroquine

Controlled Drugs

Management of controlled drugs during coronavirus pandemic. CD National Newsletter August 2020

Dermatology

EPS

Roll out of Electronic Prescription Service (EPS) Phase 4

To help you prepare for winter, NHSE are accelerating deployment of EPS Phase 4 allowing patients without a nominated pharmacy to use EPS

Heart-Failure

Hospital Only Medications (Guide to reconciliation in Primary Care)

Guidance on reconciling hospital only medicines in primary care: This guide aims to improve safety for people prescribed hospital only medicines, so that there are accurate records of these medicines within primary care practice systems.

Illicit drugs

The supply of illicit drugs into the UK has reduced significantly and will continue to reduce further. The result of this is that street prices of illicit drugs are rising, and their quality is diminishing. The illicit trade in prescription medication such as diazepam and pregabalin is increasing with reports that prices have already doubled.

To prevent the levels of theft that are likely to seriously affect operational effectiveness and the safety of all staff at this most critical time, organisations should urgently review their current security arrangements.

Inhalers

  • Guide for alternative inhalers during stock shortages (please note this document is from April, and there are no longer currently significant supply shortages. However, this document can be used if there is a need to switch patients back to their original inhalers, or to check dose equivalences).

Multi Compartment Aids

NSAIDS

Pharmacological management of Adult non-cancer chronic pain

Rheumatology

Selfcare patient support information

Shortages